CD40 induces apoptosis in carcinoma cells through activation of cytotoxic ligands of the tumor necrosis factor superfamily

Molecular and Cellular Biology

Volumn 20, Issue 15, 2000, Pages 5503-5515

  Eliopoulos, Aristides G ^a   Davies, Clare ^a   Knox, Pauline G ^a   Gallagher, Neil J ^a   Afford, Simon C ^b   Adams, David H ^b   Young, Lawrence S ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE INHIBITOR; CYTOTOXIC FACTOR; FAS LIGAND; GLYCOPROTEIN GP 39; LIGAND; TUMOR NECROSIS FACTOR DERIVATIVE;

APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CARCINOGENESIS; CARCINOMA CELL; CELL DEATH; CYTOKINE PRODUCTION; CYTOTOXICITY; HUMAN; HUMAN CELL; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION;

AMINO ACID MOTIFS; ANTIGENS, CD40; ANTIGENS, CD95; APOPTOSIS; CARCINOMA; CASPASE 3; CASPASE 8; CASPASE 9; CASPASES; CD40 LIGAND; CYCLOHEXIMIDE; CYSTEINE PROTEINASE INHIBITORS; FAS LIGAND PROTEIN; FEMALE; HUMANS; LIGANDS; MEMBRANE GLYCOPROTEINS; SERPINS; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; VIRAL PROTEINS;

EID: 0033912082     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.15.5503-5515.2000     Document Type: Article

References (75)

1. Afford, S. C., S. Randhawa, A. G. Eliopoulos, S. G. Hubscher, L. S. Young, and D. H. Adams. 1999. CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell surface Fas ligand expression and amplifies Fas-mediated hepatocyte death during allograft rejection. J. Exp. Med. 189:441-446.
2. Baker, M. P., A. G. Eliopoulos, L. S. Young, R. J. Armitage, C. D. Gregory, and J. Gordon. 1998. Prolonged phenotypic, functional and molecular changes in group I Burkitt lymphoma cells on short term exposure to CD40 ligand. Blood 92:2830-2843.
3. Barkett, M., and T. D. Gilmore. 1999. Control of apoptosis by Rel/NF-κB transcription factors. Oncogene 18:6910-6924.
4. Blake, N., S. Lee, I. Redchenko, W. Thomas, N. Steven, A. Leese, P. Steigerwald-Mullen, M. G. Kurilla, L. Frappier, and A. B. Rickinson. 1997. Human CD8(+) T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing. Immunity 7:791-802.
5. Brunet, A., A. Bonni, M. J. Zigmond, M. Z. Lin, P. Juo, L. S. Hu, M. J. Anderson, K. C. Arden, J. Blenis, and M. E. Greenberg. 1999. Akt promotes cell survival by phosphorylating and inhibiting a forkead transcription factor. Cell 96:857-868.
6. Callard, R. E., R. J. Armitage, W. C. Fanslow, and M. K. Spriggs. 1993. CD40 ligand and its role in X-linked hyper-IgM syndrome. Immunol. Today 14:559-564.
7. Cheng, G., and D. Baltimore. 1996. TANK, a co-inducer with TRAF2 of TNF- and CD40L-mediated NF-κB activation. Genes Dev. 10:963-973.
8. Cheng, J. Q., A. K. Godwin, A. Ballacosa, T. Taguchi, T. F. Franke, T. C. Hamilton, P. N. Tsichlis, and J. R. Testa. 1992. Akt2, a putative oncogene encoding a member of a subfamily of protein serine threonine kinases, is amplified in human ovarian carcinomas. Proc. Natl. Acad. Sci. USA 89:9267-9271.
9. Chinnaiyan, A. M., K. O'Rourk, M. Tewari, and V. M. Dixit. 1995. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81:505-512.
10. Choi, M. S. K., L. H. Boise, A. R. Gottschalk, J. Quintans, C. B. Thompson, and G. G. B. Klaus. 1995. The role of Bcl-x(L) in CD40-mediated rescue from anti-Mu-induced apoptosis in WEHI-231 B-cell lymphoma cells. Eur. J. Immunol. 25:1352-1357.
11. Clark, E. A., and G. Shu. 1990. Association between IL-6 and CD40 signalling: IL-6 induces phosphorylation of CD40 receptors. J. Immunol. 145: 1400-1406.
12. Cleveland, J. L., and J. N. Ihle. 1995. Contenders in FasL/TNF death signalling. Cell 81:479-482.
13. Courtois, G., S. T. Whiteside, C. H. Sibley, and A. Israel. 1997. Characterization of a mutant cell line that does not activate NF-κB in response to multiple stimuli. Mol. Cell. Biol. 17:1441-1449.
14. Devergne, O., E. Hatzivassiliou, K. M. Izumi, K. M. Kaye, M. Kleijner, E. Kieff, and G. Mosialos. 1996. TRAF1, TRAF2 and TRAF3 effect NF-κB activation by an Epstein-Barr Virus LMP1 domain important for B lymphocyte transformation. Mol. Cell. Biol. 16:7098-7108.
15. Eliopoulos, A. G., C. W. Dawson, G. Mosialos, J. E. Floettmann, M. Rowe, R. J. Armitage, J. Dawson, J. M. Zapata, D. J. Kerr, M. J. O. Wakelam, J. C. Reed, E. Kieff, and L. S. Young. 1996. CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr virus-encoded LMP1: involvement of TRAF3 as a common mediator. Oncogene 13:2243-2254.
16. Eliopoulos, A. G., N. J. Gallagher, S. M. S. Blake, C. W. Dawson, and L. S. Young. 1999. Activation of the p38 MAPK pathway by Epstein-Barr virus encoded latent membrane protein 1 (LMP1) co-regulates interleukin-6 and interleukin-8 production. J. Biol. Chem. 274:16085-16096.
17. Eliopoulos, A. G., D. J. Kerr, J. Herod, L. Hodgkin, S. Krajewski, J. C. Reed, and L. S. Young. 1995. The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and bcl-2. Oncogene 11:1217-1228.
18. Eliopoulos, A. G., M. Stack, C. W. Dawson, K. M. Kaye, L. Hodgkin, S. Sihota, M. Rowe, and L. S. Young. 1997. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-κB pathway involving TNF receptor-associated factors. Oncogene 14:2899-2916.
19. Eliopoulos, A. G., and L. S. Young. 1998. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1). Oncogene 16:1731-1742.
20. Fanslow, W. C., S. P. Srinivasan, R., M. G. Gibson, M. K. Spriggs, and R. J. Armitage. 1994. Structural characteristics of CD40 ligand that determine biological function. Semin. Immunol. 6:267-278.
21. Friesen, C., I. Herr, P. H. Krammer, and K. M. Debatin. 1996. Involvement of the CD95 (Apo-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat. Med. 2:574-577.
22. Funakoshi, S., D. L. Longo, M. Beckwith, D. K. Conley, G. Tsarfaty, I. Tsarfaty, R. J. Armitage, W. C. Fanslow, M. K. Spriggs, and W. J. Murphy. 1994. Inhibition of B-cell lymphoma growth by CD40 stimulation. Blood 83:2787-2794.
23. Garrone, P., E.-M. Neidhardt, E. Garcia, L. Galibert, C. van Kooten, and J. Banchereau. 1995. Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J. Exp. Med. 182:1265-1273.
24. Gilligan, M. G., P. Knox, S. Weedon, R. Barton, D. J. Kerr, P. Searle, and L. S. Young. 1998. Adenoviral delivery of B7-1 (CD80) increases the immunogenicity of human ovarian and cervical carcinoma cells. Gene Ther. 5:965-974.
25. Goldstein, M. D., and T. H. Watts. 1996. Identification of distinct domains in CD40 involved in B7.1 induction or growth inhibition. J. Immunol. 157:2837-2843.
26. Gordon, J. 1995. CD40 and its ligand: central players in B lymphocyte survival, growth and differentiation. Blood Rev. 9:53-56.
27. Grell, M., G. Zimmermann, E. Gottfried, C.-M. Chen, U. Grunwald, D. C. S. Huang, Y.-H. W. Lee, H. Durkop, H. Engelmann, P. Scheurich, H. Wajant, and A. Strasser. 1999. Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF. EMBO J. 18:3034-3043.
28. Grimm, S., M. K. A. Bauer, P. A. Baeuerle, and K. Schulze-Osthoff. 1996. Bcl-2 down-regulates the activity of transcription factor NF-κB induced upon apoptosis. J. Cell Biol. 134:13-23.
29. Hanissian, S. H., and R. S. Geha. 1997. JAK3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells. Immunity 6:379-387.
30. Hayward, A. R., J. Levy, F. Facchetti, L. Notarangelo, H. D. Ochs, A. Etzioni, J.-Y. Bonnefoy, M. Cosyns, and A. Weinberg. 1997. Cholangiopathy and tumours of the pancreas, liver and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J. Immunol. 158:977-983.
31. Hess, S., and H. Engelmann. 1996. A novel function of CD40: induction of cell death in transformed cells. J. Exp. Med. 183:159-167.
32. Hirano, A., D. L. Longo, D. D. Taub, D. K. Ferris, L. S. Young, A. G. Eliopoulos, A. Agathanggelou, N. Cullen, J. Macartney, W. C. Fanslow, and W. J. Murphy. 1999. Inhibition of human breast carcinoma growth by a soluble recombinant human CD40 ligand. Blood 93:2999-3007.
33. Hostager, B. S., Y. Hsing, D. E. Harms, and G. A. Bishop. 1996. Different CD40-mediated signalling events require distinct CD40 structural features. J. Immunol. 157:1047-1053.
34. Hueber, A.-O., M. Zornig, D. Lyon, T. Suda, S. Nagata, and G. I. Evan. 1997. Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. Science 278:1305-1309.
35. Ishida, T., S. Mizushima, S. Azuma, N. Kobayashi, T. Tojo, K. Suzuki, S. Aizawa, T. Watanabe, G. Mosialos, E. Kieff, T. Yamamoto, and J. Inoue. 1996. Identification of TRAF6, a novel tumour necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J. Biol. Chem. 271:28745-28748.
36. Jaattela, M., M. Benedict, M. Tewari, J. A. Shayman, and V. M. Dixit. 1995. Bcl-x and bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene 10:2297-2305.
37. Kashiwada, M., Y. Shirakata, J.-I. Inoue, H. Nakano, K. Okazaki, K. Okumura, T. Yamamoto, H. Nagaoka, and T. Takemori. 1998. Tumor necrosis factor receptor-associated factor 6 (TRAF6) stimulates extracellular signal-regulated kinase (ERK) activity in CD40 signalling along a Ras-independent pathway. J. Exp. Med. 187:237-244.
38. Kasibhatla, S., T. Brunner, L. Genestier, F. Echeverri, A. Mahboubi, and D. R. Green. 1998. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-κB and AP-1. Mol. Cell 1:543-551.
39. Kawabe, T., T. Naka, K. Yoshida, T. Tanaka, H. Fujiwara, S. Suematsu, N. Yoshida, T. Kishimoto, and H. Kikutani. 1994. The immune responses in CD40 deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1:167-178.
40. Kawahara, A., T. Kobayashi, and S. Nagata. 1998. Inhibition of Fas-induced apoptosis by Bcl-2. Oncogene 17:2549-2554.
41. Kiener, P. A., P. M. Davis, B. M. Rankin, S. J. Klebanoff, J. A. Ledbetter, G. C. Starling, and W. C. Liles. 1997. Human monocytic cells contain high levels of intracellular Fas ligand: rapid release following cellular activation. J. Immunol. 159:1594-1598.
42. Lee, H. H., H. Dadgostar, Q. Cheng, J. Shu, and G. Cheng. 1999. NF-κB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signalling in B lymphocytes. Proc. Natl. Acad. Sci. USA 96:9136-9141.
43. Lee, H. H., P. W. Dempsey, T. P. Parks, X. Zhu, D. Baltimore, and G. Cheng. 1999. Specificities of CD40 signaling: involvement of TRAF2 in CD40-induced NF-κB activation and intercellular adhesion molecule-1 up-regulation. Proc. Natl. Acad. Sci. USA 96:1421-1426.
44. Lee, S. Y., A. Reichlin, A. Santana, K. A. Sokol, M. C. Nussenzweig, and Y. Choi. 1997. TRAF2 is essential for JNK but not NF-κB activation and regulates lymphocyte proliferation and survival. Immunity 7:703-713.
45. Lin, B., C. Williams-Skipp, Y. Tao, M. S. Schleicher, L. L. Cano, R. C. Duke, and R. I. Scheinman. 1999. NF-κB functions as both a proapoptotic and antiapoptotic regulatory factor within a single cell type. Cell Death Differ. 6:570-582.
46. Mapara, M. Y., R. Bargou, C. Zugck, H. Dohner, F. Ustaoglou, R. R. Jonker, P. H. Krammer, and B. Dorken. 1993. APO-1 mediated apoptosis or proliferation in human chronic B-lymphocytic leukemia - correlation with bcl-2 oncogene expression. Eur. J. Immunol. 23:702-708.
47. Martinez-Lorenzo, M. J., M. A. Alava, S. Gamen, K. J. Kim, A. Chuntharapai, A. Pineiro, J. Naval, and A. Anel. 1998. Involvement of Apo2 ligand/TRAIL in activation induced death in Jurkat and human peripheral blood T cells. Eur. J. Immunol. 28:2714-2725.
48. McCarthy, J. V., J. Ni, and V. M. Dixit. 1998. RIP2 is a novel NF-κB-activating and cell death-inducing kinase. J Biol. Chem. 273:16968-16975.
49. McGrory, W. J., D. S. Bautista, and F. L. Graham. 1988. A simple technique for the rescue of early region-1 mutations into infectious human adenovirus type-5. Virol. 163:614-617.
50. McWhirter, S. M., S. S. Pullen, J. M. Holton, J. J. Crute, M. R. Kehry, and T. Alber. 1999. Crystallographic analysis of CD40 recognition and signaling by human TRAF2. Proc. Natl. Acad. Sci. USA 96:8408-8413.
51. Miura, M., R. M. Friedlander, and J. Yuan. 1995. Tumor necrosis factor-induced apoptosis is mediated by a crmA-sensitive cell death pathway. Proc. Natl. Acad. Sci. USA 92:8318-8322.
52. Morris, A. E., R. L. Remmele, R. Klinke, B. M. Macduff, W. C. Fanslow, and R. J. Armitage. 1999. Incorporation of an isoleucine zipper motif enhances the biological activity of soluble CD40L (CD154). J. Biol. Chem. 274:418-423.
53. Natoli, G., A. Costanzo, A. Ianni, D. J. Templeton, J. R. Woodgett, C. Balsano, and M. Levrerop. 1997. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science 275:200-203.
54. Noelle, R. J. 1996. CD40 and its ligand in host defense. Immunity 4:415-419.
55. Peguet-Navarro, J., C. Dalbiez-Gauthier, C. Moulon, O. Berthier, A. Reano, M. Gaucherand, J. Banchereau, F. Rousset, and D. Schmitt. 1997. CD40 ligation of human keratinocytes inhibits their proliferation and induces their differentiation. J. Immunol. 158:144-152.
56. Pitti, R. M., S. A. Marsters, S. Ruppert, C. J. Donahue, A. Moore, and A. Ashkenazi. 1996. Induction of apoptosis by Apo-2 ligand, a new member of the tumour necrosis factor cytokine family. J. Biol. Chem. 271:12687-12690.
57. Ren, C. L., T. Morio, S. F. Fu, and R. S. Geha. 1994. Signal transduction via CD40 involves activation of lyn kinase and phosphatidylinositol-3-kinase and phosphorylation of phospholipase Cγ2. J. Exp. Med. 179:673-680.
58. Rothe, M., V. Sarma, V. M. Dixit, and D. V. Goeddel. 1995. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269:1424-1427.
59. Rothstein, T. L., J. K. M. Wang, D. J. Panka, L. C. Foote, Z. Wang, B. Stanger, H. Cui, S. Ju, and A. Marshak-Rothstein. 1995. Protection against Fas-dependent Th-1-mediated apoptosis by antigen receptor engagement in B cells. Nature (London) 374:163-165.
60. Rytomaa, M., L. M. Martins, and J. Downward. 1999. Involvement of FADD and caspase-8 signalling in detachment-induced apoptosis. Curr. Biol. 9:1043-1046.
61. Sakata, N., H. R. Patel, N. Terada, A. Aruffo, G. L. Johnson, and E. W. Gelfand. 1995. Selective activation of c-Jun kinase-activated protein kinase by CD40 on human B cells. J. Biol. Chem. 270:30823-30828.
62. Sarma, V., Z. Lin, L. Clark, B. M. Rust, M. Tewari, R. J. Noelle, and V. M. Dixit. 1995. Activation of the B-cell surface receptor CD40 induces A20, a novel zinc-finger protein that inhihits apoptosis. J. Biol. Chem. 270:12343-12346.
63. Scaffidi, C., S. Fulda, A. Srinivasan, C. Friesen, K. Li, K. J. Tomaselli, K.-M. Debatin, P. H. Krammer, and M. E. Peter. 1998. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17:1675-1687.
64. Smith, C. A., T. Farrah, and R. G. Goodwin. 1994. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death. Cell 76:959-962.
65. Tewari, M., and V. M. Dixit. 1995. Fas- and tumour necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J. Biol. Chem. 270:3255-3260.
66. Tsukamoto, N., N. Kobayashi, S. Azuma, T. Yamamoto, and J.-I. Inoue. 1999. Two differently regulated nuclear factor κB activation pathways triggered by the cytoplasmic tail of CD40. Proc. Natl. Acad. Sci. USA 96:1234-1239.
67. VanArsdale, T. L., S. L. VanArsdale, W. R. Force, B. N. Walter, G. Mosialos, E. Kieff, J. C. Reed, and C. F. Ware. 1997. Lymphotoxin-b receptor signalling complex: role of tumour necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor κB. Proc. Natl. Acad. Sci. USA 94:2460-2465.
68. Wang, C-Y., M. W. Mayo, and A. S. Baldwin Jr. 1996. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274:784-787.
69. Wang, C.-Y., M. W. Mayo, R. G. Korneluk, D. V. Goeddel, and A. S. Baldwin. 1918. NF-κB anti-apoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP1 to suppress caspase-8 activation. Science 281:1680-1683.
70. Wilkinson, G. W. G., and A. Akrigg. 1992. Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector. Nucleic Acids Res. 20:2233-2239.
71. Wood, K. M., M. Roff, and R. T. Hay. 1998. Defective IkBa in Hodgkin cell lines with constitutively active NF-κB. Oncogene 16:2131-2139.
72. Xu, J., T. M. Foy, J. D. Laman, E. A. Elliot, J. J. Dun, T. J. Waldscmidt, J. Elsemore, R. J. Noelle, and R. A. Flavell. 1994. Mice deficient for the CD40 ligand. Immunity 1:423-431.
73. Younes, A., V. Snell, U. Consoli, K. Clodi, S. Zhao, J. L. Palmer, E. K. Thomas, R. J. Armitage, and M. Andreff. 1998. Elevated levels of biologically active soluble CD40 ligand in the serum of patients with chronic lymphocytic leukaemia. Br. J. Haematol. 100:135-141.
74. Young, L. S., C. W. Dawson, K. W. Brown, and A. B. Rickinson. 1989. Identification of a human epithelial cell surface protein sharing an epitope with C3d/Epstein-Barr virus receptor molecule of B lymphocytes. Int. J. Cancer 43:786-794.
75. Young, L. S., A. G. Eliopoulos, N. J. Gallagher, and C. W. Dawson. 1998. CD40 and epithelial cells: across the great divide. Immunol. Today 19:502-505.